KRAS G12C inhibitor 18 T40285

Product Introduction
Bioactivity


英文名: KRAS G12C inhibitor 18

描述: KRAS G12C inhibitor 18 is a potent, orally active compound that inhibits KRAS G12C and exhibits anti-tumor activities.

体外活性: KRAS G12C inhibitor 18 (compound 34) inhibits the growth of many KRas G12C mutant tumor cell lines (such as H358, SW1436, MiaPaca-2 cells, etc.)[1].

体内活性: KRAS G12C inhibitor 18 exhibits a dose dependent inhibiton of pERK and active KRas after a single dose treatment from 12.5 to 100 mg/kg at 8 hours[1]. KRAS G12C inhibitor 18 (30 mg/kg; p.o.; twice daily) exhibits anti-tumor growth activity in lung cancer H358 xenograft mouse model[1].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

关键字: KRAS G-12C inhibitor 18 | KRAS G12C inhibitor 18

KRAS G12C inhibitor 18 T40285信息由TargetMol中国为您提供，如您想了解更多关于KRAS G12C inhibitor 18 T40285报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途